Find clinical trials for Asthma in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia

Allergic Rhinitis

Nasal Polyps

Rhinitis

Rhinosinusitis

Chronic Obstructive Pulmonary Disease

Lung Diseases

Asthma trials near Valencia, VC, ESP:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling

Asthma

Drug: Placebo

Drug: Benralizumab

Phase 3

AstraZeneca

Valencia, Spain and 83 other locations

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma (HORIZON)

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling

Asthma

Biological: Tezepelumab

Other: Placebo

Phase 3

AstraZeneca

Valencia, Spain and 115 other locations

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH)

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Enrolling

Asthma

Drug: Atuliflapon

Drug: Placebo

Phase 2

AstraZeneca

Xàtiva, Spain and 381 other locations

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NIMBLE)

of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...

Active, not recruiting

Asthma

Biological: GSK3511294 (Depemokimab)

Biological: Mepolizumab

Phase 3

GlaxoSmithKline (GSK)

Valencia, Spain and 419 other locations

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations (Levante)

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Enrolling

Asthma

Device: Inhaler

Drug: AZD8630

Phase 2

AstraZeneca

Valencia, Spain and 192 other locations

Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).

propellant (HFA-152a) compared to the currently approved one (HFA-134a) in the medication (CHF5993) in patients with moderate to severe asthma...

Enrolling

Asthma

Drug: CHF5993 200/6/12.5 μg pMDI HFA-152a

Drug: Inhaler CHF5993 200/6/12.5 μg pMDI HFA-134a

Phase 3

Chiesi

Castello de la Plana, Spain and 142 other locations

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...

Enrolling

Asthma

Drug: Albuterol sulfate

Drug: TEV-56248

Phase 3

Teva Pharmaceuticals

Valencia, Spain and 274 other locations

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)

variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...

Active, not recruiting

Asthma

Drug: BFF pMDI 320/9 μg

Drug: BFF MDI 320/9.6 μg

Phase 3

AstraZeneca

Valencia, Spain and 362 other locations

Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites (MM09-SIT-023)

in patients with rhinitis/rhinoconjunctivitis with mild to moderate asthma, sensitised to Dermatophagoides pteronyssinus and /or Dermatophag...

Enrolling

Asthma, Allergic

Rhinoconjunctivitis

Biological: 10,000 MM09

Biological: 30,000 MM09

Phase 3

Inmunotek

Valencia, Spain and 17 other locations

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) (AGILE)

profile of GSK3511294 (Depemokimab) in participants with severe asthma with an eosinophilic phenotype following completion of clinical studi...

Active, not recruiting

Asthma

Biological: GSK3511294 (Depemokimab)

Phase 3

GlaxoSmithKline (GSK)

Valencia, Spain and 156 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Asthma in .css-epvm6{white-space:nowrap;}Valencia, VC

Related conditions:

Asthma trials near Valencia, VC, ESP:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma (HORIZON)

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH)

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NIMBLE)

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations (Levante)

Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)

Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites (MM09-SIT-023)

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) (AGILE)

Find clinical trials for Asthma in Valencia, VC